Event Summary
The NHLBI will host a virtual workshop on research priorities in the treatment of mitral valve prolapse on December 12 and 13, 2024. The workshop will consist of researchers in the field who will review the state of the science and identify research needs and opportunities for the treatment of individuals with mitral valve prolapse, including those who may be at risk for sudden cardiac arrest or sudden cardiac death.
Description
Research in the Treatment of Mitral Valve Prolapse 2024 will examine both the clinical and basic science of mitral valve prolapse (MVP), including diagnostic imaging, risk assessment, clinical management, surgical and transcatheter intervention, genetics, and disease mechanism. This 2024 workshop is an update of the 2021 workshop and part of the NHLBI’s implementation of the Cardiovascular Advances in Research and Opportunities Legacy (CAROL) Act.
Registration Close Date:
Contact Information:
For programmatic questions, please email Frank Evans, Ph.D. at Frank.Evans@nih.gov and Jamie Gulin at Jamie.Gulin@nih.gov.
For logistical questions, please email the NHLBI Workshop Support Program Team at NHLBIWorkshopSupport@nih.gov.
Individuals requiring Sign Language Interpreters or other reasonable accommodations to facilitate their participation in this event should contact the NHLBI Workshop Support Program Team: ATTN: Brittney Villafana at NHLBIWorkshopSupport@nih.gov at least five (5) days prior to the commencement of the workshop.